ANIX Covered Call Strategy
ANIX (Anixa Biosciences, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Anixa Biosciences, Inc. (ANIX) is a biotechnology company dedicated to pioneering therapies and vaccines. Its core mission revolves around addressing critical, unmet medical needs, particularly within the fields of oncology (cancer) and infectious diseases. Among its therapeutic pipeline, Anixa is developing a novel chimeric endocrine receptor T-cell (CER-T) technology, an innovative adaptation of CAR-T, specifically for ovarian cancer treatment. The company is also engaged in the discovery and development of antiviral drug candidates to combat COVID-19, focusing on the inhibition of specific viral protein functions. On the vaccine front, Anixa's initiatives include a vaccine designed to target triple-negative breast cancer and a distinct preventative vaccine aimed at ovarian cancer. Beyond specific therapies and vaccines, Anixa also has immuno-therapy drugs for various cancers in its development portfolio.
ANIX (Anixa Biosciences, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $109.9M, a beta of 0.60 versus the broader market, a 52-week range of 2.32-5.46, average daily share volume of 189K, a public-listing history dating back to 1983, approximately 4 full-time employees. These structural characteristics shape how ANIX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.60 indicates ANIX has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a covered call on ANIX?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
ANIX snapshot
As of August 14, 2026, spot at $3.21, ATM IV 172.40%, IV rank 32.40%, expected move 49.43%. The covered call on ANIX below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this covered call structure on ANIX specifically: ANIX IV at 172.40% is mid-range versus its 1-year history, so the credit collected on a ANIX covered call sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 49.43% (roughly $1.59 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ANIX expiries trade a higher absolute premium for lower per-day decay. Position sizing on ANIX should anchor to the underlying notional of $3.21 per share and to the trader's directional view on ANIX stock.
ANIX covered call setup
The ANIX covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ANIX at $3.21 on that close, the first option leg uses a $3.37 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ANIX chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ANIX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $3.21 | long |
| Sell 1 | Call | $3.37 | N/A |
ANIX covered call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
ANIX covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on ANIX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use covered call on ANIX
Covered calls on ANIX are an income strategy run on existing ANIX stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
ANIX thesis for this covered call
The market-implied 1-standard-deviation range for ANIX extends from approximately $1.62 on the downside to $4.80 on the upside. A ANIX covered call collects premium on an existing long ANIX position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether ANIX will breach that level within the expiration window. Current ANIX IV rank near 32.40% is mid-range against its 1-year distribution, so the IV signal is neutral; the covered call thesis on ANIX should anchor more to the directional view and the expected-move geometry. As a Healthcare name, ANIX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ANIX-specific events.
ANIX covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ANIX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ANIX alongside the broader basket even when ANIX-specific fundamentals are unchanged. Short-premium structures like a covered call on ANIX carry tail risk when realized volatility exceeds the implied move; review historical ANIX earnings reactions and macro stress periods before sizing. Always rebuild the position from current ANIX chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on ANIX?
- A covered call on ANIX is the covered call strategy applied to ANIX (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With ANIX stock at $3.21 on the most recent close, the strikes shown on this page are snapped to the nearest listed ANIX chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are ANIX covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the ANIX covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 172.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ANIX covered call?
- The breakeven for the ANIX covered call priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The ANIX market-implied 1-standard-deviation expected move in the same options snapshot is approximately 49.43%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on ANIX?
- Covered calls on ANIX are an income strategy run on existing ANIX stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current ANIX implied volatility affect this covered call?
- ANIX ATM IV is at 172.40% with IV rank near 32.40%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.